Cheyne Capital Management Uk Llp Continues to Hold Position in Scotts Miracle Gro Co (SMG); As Gilead Sciences (GILD) Stock Declined, Holder Btr Capital Management Trimmed Position by $604,827

February 22, 2018 - By Henry Gaston

Btr Capital Management Inc decreased its stake in Gilead Sciences Inc (GILD) by 14.05% based on its latest 2017Q3 regulatory filing with the SEC. Btr Capital Management Inc sold 7,467 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 45,683 shares of the health care company at the end of 2017Q3, valued at $3.70 million, down from 53,150 at the end of the previous reported quarter. Btr Capital Management Inc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $104.03B market cap company. The stock decreased 1.30% or $1.05 during the last trading session, reaching $79.64. About 5.33M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 22, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Jonathan Lourie increased its stake in Scotts Miracle Gro Co (SMG) by 150% based on its latest 2017Q3 regulatory filing with the SEC. Cheyne Capital Management Uk Llp bought 42,000 shares as the company’s stock declined 6.19% while stock markets rallied. The hedge fund run by Jonathan Lourie held 70,000 shares of the agricultural chemicals company at the end of 2017Q3, valued at $3.12 million, up from 28,000 at the end of the previous reported quarter. Cheyne Capital Management Uk Llp who had been investing in Scotts Miracle Gro Co for a number of months, seems to be bullish on the $5.12B market cap company. The stock decreased 0.85% or $0.77 during the last trading session, reaching $89.93. About 318,429 shares traded. The Scotts Miracle-Gro Company (NYSE:SMG) has risen 31.99% since February 22, 2017 and is uptrending. It has outperformed by 15.29% the S&P500.

Since August 25, 2017, it had 0 insider buys, and 5 sales for $3.90 million activity. $1.51 million worth of The Scotts Miracle-Gro Company (NYSE:SMG) was sold by HAGEDORN JAMES on Friday, August 25. $500,551 worth of The Scotts Miracle-Gro Company (NYSE:SMG) was sold by Mistretta Nancy G. on Friday, October 13. Shares for $1.51M were sold by Hagedorn Partnership – L.P.. HAGEDORN SUSAN also sold $1.51 million worth of The Scotts Miracle-Gro Company (NYSE:SMG) shares. $122,195 worth of The Scotts Miracle-Gro Company (NYSE:SMG) was sold by Coleman Thomas Randal on Saturday, September 30. On Friday, September 8 the insider HAGEDORN PAUL sold $1.51 million.

Cheyne Capital Management Uk Llp, which manages about $8.62B and $277.10 million US Long portfolio, decreased its stake in Micron Technology Inc (Prn) by 2.15M shares to 53,008 shares, valued at $3.05M in 2017Q3, according to the filing. It also reduced its holding in Red Hat Inc (Prn) by 1.12M shares in the quarter, leaving it with 1.00M shares, and cut its stake in Intel Corp (Prn).

Among 7 analysts covering Scotts Miracle-Gro Company (The) (NYSE:SMG), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Scotts Miracle-Gro Company (The) had 13 analyst reports since March 22, 2016 according to SRatingsIntel. KeyBanc Capital Markets maintained The Scotts Miracle-Gro Company (NYSE:SMG) on Monday, August 28 with “Hold” rating. The stock of The Scotts Miracle-Gro Company (NYSE:SMG) has “Buy” rating given on Thursday, December 8 by Bank of America. As per Wednesday, November 8, the company rating was maintained by Bank of America. KeyBanc Capital Markets maintained the shares of SMG in report on Wednesday, November 22 with “Hold” rating. The rating was maintained by KeyBanc Capital Markets with “Hold” on Monday, October 16. The rating was upgraded by JP Morgan on Thursday, August 4 to “Overweight”. J.P. Morgan downgraded The Scotts Miracle-Gro Company (NYSE:SMG) rating on Wednesday, November 8. J.P. Morgan has “Hold” rating and $99.0 target. The stock of The Scotts Miracle-Gro Company (NYSE:SMG) has “Hold” rating given on Wednesday, January 11 by SunTrust. As per Wednesday, January 11, the company rating was downgraded by Suntrust Robinson. As per Wednesday, November 8, the company rating was downgraded by JP Morgan.

Investors sentiment decreased to 0.94 in 2017 Q3. Its down 0.30, from 1.24 in 2017Q2. It turned negative, as 33 investors sold SMG shares while 103 reduced holdings. 39 funds opened positions while 89 raised stakes. 38.40 million shares or 1.70% less from 39.06 million shares in 2017Q2 were reported. Dimensional Fund Advsr Limited Partnership invested in 486,538 shares or 0.02% of the stock. Cheyne Cap Management (Uk) Llp reported 70,000 shares. Tiaa Cref Inv Management Ltd Liability Corporation holds 0.01% in The Scotts Miracle-Gro Company (NYSE:SMG) or 137,973 shares. S Muoio And Company Limited Liability Company accumulated 8,700 shares. Hwg Ltd Partnership has 80 shares for 0.01% of their portfolio. Aqr Cap Mgmt invested 0.01% in The Scotts Miracle-Gro Company (NYSE:SMG). Raymond James Fincl Advsrs holds 0% or 7,856 shares in its portfolio. Bahl & Gaynor Incorporated reported 0.02% in The Scotts Miracle-Gro Company (NYSE:SMG). Vantage Investment Advisors Ltd Liability Corp has invested 0.01% in The Scotts Miracle-Gro Company (NYSE:SMG). Carnegie Cap Asset Mngmt Llc stated it has 13,815 shares or 0.16% of all its holdings. Barclays Public Ltd Limited Liability Company owns 5,221 shares or 0% of their US portfolio. Janney Montgomery Scott Ltd Com holds 0.01% or 10,607 shares in its portfolio. Bb&T Corporation holds 0.17% or 89,937 shares in its portfolio. Dynamic Mgmt holds 5,650 shares. Tower Research Capital (Trc) has invested 0% in The Scotts Miracle-Gro Company (NYSE:SMG).

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on May, 1. They expect $1.59 EPS, down 27.73% or $0.61 from last year’s $2.2 per share. GILD’s profit will be $2.08 billion for 12.52 P/E if the $1.59 EPS becomes a reality. After $1.60 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Citigroup on Wednesday, February 8. The firm earned “Buy” rating on Tuesday, November 8 by Mizuho. On Thursday, November 5 the stock rating was upgraded by Piper Jaffray to “Overweight”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Monday, November 13 by Argus Research. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Outperform” rating by Oppenheimer on Thursday, February 11. The firm has “Buy” rating given on Wednesday, October 5 by Jefferies. Wells Fargo maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, December 4 with “Market Perform” rating. As per Wednesday, December 20, the company rating was downgraded by Credit Suisse. Piper Jaffray maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Friday, July 24. Piper Jaffray has “Overweight” rating and $131 target. The firm has “Outperform” rating given on Wednesday, February 3 by Credit Suisse.

Since August 30, 2017, it had 0 insider buys, and 14 insider sales for $55.76 million activity. $3.95M worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Alton Gregg H. The insider Washington Robin L sold $4.40 million. Meyers James R had sold 100,000 shares worth $8.02 million on Tuesday, January 16. WILSON GAYLE E also sold $4.68 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, February 9.

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It improved, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Hilltop Inc accumulated 3,173 shares. Bradley Foster And Sargent Ct has 64,349 shares. Lenox Wealth Mngmt Incorporated holds 0.29% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 10,392 shares. Moreover, Patten Group Inc has 0.02% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 50,032 shares. Rafferty Asset Limited Liability Company holds 0.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 18,984 shares. Dodge And Cox reported 0.65% in Gilead Sciences, Inc. (NASDAQ:GILD). Silvercrest Asset Mngmt Ltd holds 44,505 shares. 66,194 were reported by Eqis Capital Mgmt. Numeric Llc holds 1.72% or 2.76 million shares in its portfolio. Checchi Advisers Limited Liability holds 10,325 shares. Tarbox Family Office reported 6,559 shares stake. Crestwood Gp Ltd Llc has 0.02% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Hirtle Callaghan Limited Liability accumulated 0% or 404 shares. Nbt Bancshares N A New York reported 0.51% in Gilead Sciences, Inc. (NASDAQ:GILD). Hightower Advisors Ltd holds 476,390 shares or 0.33% of its portfolio.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>